Sponsor:
University of Washington
Code:
NCT04282187
Conditions
Acute Myeloid Leukemia
Essential Thrombocythemia
Myelodysplastic Syndrome
Myelodysplastic/Myeloproliferative Neoplasm
Myeloproliferative Neoplasm
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Decitabine
Ruxolitinib
Fedratinib
Questionnaire Administration
Pacritinib
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-07. This information was provided to ClinicalTrials.gov by University of Washington on 2025-09-23.